DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Fleseriu M, Biller BMK, Findling JW. et al.
Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome.
J Clin Endocrinol Metab 2012;
97: 2039-2049
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.